Active Ingredient
Amino acids 2% , BARLEY MALT 1%
Nerve Mushroom Gummies Chewable Gel
FDA Label NDC 83739-003
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Xian Chiang Company Limited for the product Nerve Mushroom Gummies (NDC 83739-003). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, do not use, when using section, stop use section, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Purpose
Promote brain health Regulate the immune system
Uses
Regulating immunity
Warnings
For internal use only
Do Not Use
If you are allergic to any ingredients
When Using Section
When using this product , do not take other medications at the same time If taking antibiotics at the same time , please interval at least 2 hours orfollow medical advice.
If discomfort occurs after consumption , please stop using and consult adoctor
Stop Use Section
No side effects
Keep Out Of Reach Of Children
Children , pregnant women , and nursing mothers should not consume it .
Instructions
Once a day , 2 gummies each time , taken with warm water
Seal and place in a cool and dry placem
This product cannot replace medication for treatment
Other Information
Other information store at 20-30°C ( 68-77F )
protect from excessive moisture
Inactive Ingredient
Lsion's Mane ( Dual Extraction ) , Acetylenelcarnitine , Citicoline , Alpha Lipoic acid, Curcumin , Phosphatidylserine ( sunflower lecithin ) , N-AcetylL-Tyrosine , Thiamine ( B1 ) , Piperine , Vitamin B6 , Vitamin B9 , Vitamin B
Package Label.Principal Display Panel
83739-003-01 (83739 003 01)
* Please review the disclaimer below.
